LifeStance Health GroupLFST -0.81%56 Cash-to-Debt is 0.43 as of Mar. 2026, which is 54% above its 10-year median of 0.28. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.27 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 62.72% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. LifeStance Health Group's cash to debt ratio for the quarter that ended in Mar. 2026 was 0.43.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, LifeStance Health Groupcouldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for LifeStance Health Group's Cash-to-Debt or its related term are showing as below:
LFST'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04 Med: 0.28 Max: 1.76
Current: 0.43
During the past 7 years, LifeStance Health Group's highest Cash to Debt Ratio was 1.76. The lowest was 0.04. And the median was 0.28.
LFST's Cash-to-Debt is ranked worse than 62.72% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 0.79
vs LFST: 0.43
LifeStance Health Group (NAS:LFST) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
LifeStance Health Group Cash-to-Debt Related Terms
LifeStance Health Group Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Care Facilities subindustry, LifeStance Health Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Cash-to-Debt of 0.43 as of Mar. 2026. This is 54% above median its historical median of 0.28. Over the past decade, LifeStance Health Group's Cash-to-Debt has ranged from 0.04 to 1.76. According to the industry distribution chart, LifeStance Health Group ranks #419 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 62.7%.
Is LifeStance Health Group's Cash-to-Debt too high?
LifeStance Health Group's current Cash-to-Debt of 0.43 is 54% above median its 10-year median of 0.28. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 1.76. The Healthcare Providers & Services industry median Cash-to-Debt is 0.79. LifeStance Health Group's value of 0.43 is 45.6% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #419 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Cash-to-Debt compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #419 out of 668 companies for Cash-to-Debt. This places LifeStance Health Group in the lower half of its industry. The industry median Cash-to-Debt is 0.79. LifeStance Health Group's value of 0.43 is 45.6% below this benchmark. Historically, LifeStance Health Group's own Cash-to-Debt has ranged from 0.04 to 1.76 over the past decade. While the company's 10-year median is 0.28 vs. the industry median of 0.79, LifeStance Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.79, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Cash-to-Debt of 0.43 is 45.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Cash-to-Debt is 0.43, which is 54% above median its own 10-year median of 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.27, compared to a current price of $10.71 — trading 29.4% above its estimated fair value. The current Cash-to-Debt is 0.43, which is 54% above median its 10-year median of 0.28 and 45.6% below the Healthcare Providers & Services industry median of 0.79. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Cash-to-Debt is 0.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.71 is trading 29.4% above its estimated GF Value™ of $8.27.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
Cash-to-Debt: 0.43 (54% above median its 10-year median of 0.28)
GF Value™: $8.27 vs. price of $10.71 (29.4% above fair value)
Industry Position: 45.6% below the Healthcare Providers & Services median (#419 of 668)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
